Depression (Mood Disorder)

Depression (also termed major depressive disorder, clinical depression, or unipolar depression in medical contexts) is a mental health condition characterized by persistent low mood, anhedonia (loss of pleasure in activities), and functional impairment lasting at least two weeks ^[1]. The World Health Organization estimates depression affects approximately 280 million people globally, making it the leading cause of disability worldwide ^[2]. Depression exists on a spectrum, from subsyndromal sadness to severe depression with psychotic features, and it is distinguished from temporary grief or sadness by its persistence, pervasiveness, and impact on daily functioning ^[3].

Depression is recognized across cultures, though how it is understood, named, and treated varies substantially. Western biomedical frameworks conceptualize depression primarily as an individual psychiatric disorder; some cultural contexts understand it as relational (affecting the person's social bonds), spiritual (a disconnection from sacred sources), or social (a rational response to unjust or oppressive conditions) ^[4]. These are not mutually exclusive frameworks -- many individuals and healers integrate multiple perspectives.

Melancholia, a state of profound sadness and withdrawal, has been documented in medical and philosophical texts for over two millennia. Ancient Greek physicians (Hippocrates, Galen) attributed it to an imbalance of black bile; Islamic physicians like Al-Razi and Avicenna described melancholia as a distinct medical condition; Chinese medicine linked depression-like states to imbalances in qi (vital energy) ^[5]. These frameworks were not precursors to modern psychiatry -- they were complete systems of understanding that integrated physiology, psychology, and social context in different ways than contemporary medicine does.

In 19th-century Europe and North America, melancholia became formalized within asylum psychiatry. The term "depression" gradually replaced melancholia in the early 20th century, reflecting both evolving medical understanding and changing social framings of mood disturbance ^[6]. The introduction of antidepressant medications (monoamine oxidase inhibitors in the 1950s, tricyclic antidepressants in the 1960s, and selective serotonin reuptake inhibitors in the 1980s-1990s) catalyzed a shift toward biological explanations of depression, particularly the serotonin hypothesis ^[7].

In the latter 20th century, psychotherapeutic models -- cognitive-behavioral therapy, interpersonal therapy, psychodynamic approaches -- emerged alongside pharmacotherapy, with evidence supporting multiple effective pathways ^[8]. Contemporary depression research integrates biological, psychological, and social models, though the relative weight of each remains contested.

The following sections describe depression using DSM-5 and ICD-11 diagnostic criteria, which are the dominant clinical frameworks in English-language psychiatric practice. Note: These frameworks were developed primarily by Western (particularly North American and European) psychiatrists and may not capture all culturally relevant presentations of depression ^[9].

Depression is understood through multiple causal frameworks, and genuine expert disagreement persists about their relative importance ^[12]. This section presents the major models without resolving their primacy.

Depression is the most common mental health disorder globally. The WHO estimates lifetime prevalence at 5-10% in developed nations, with higher rates in low- and middle-income countries when accounting for underdiagnosis ^[2]. However, diagnostic rates vary dramatically by region, reflecting differences in access to mental health services, cultural frameworks for understanding distress, and screening practices rather than true prevalence differences alone ^[24].

Risk factors include: genetic predisposition, early adversity (childhood abuse, neglect, loss), trauma exposure, chronic stress, medical illness (diabetes, heart disease, chronic pain), substance use, and social factors (poverty, discrimination, social isolation) ^[25]. Women are diagnosed with depression at roughly twice the rate of men, though reasons for this difference are debated -- biological vulnerability, differential help-seeking, diagnostic bias, or genuine higher prevalence due to gender-based stress and trauma ^[26]. Depression onset typically occurs in late adolescence to early adulthood, though it can emerge at any age ^[1].

Cultural variation: Diagnostic rates of depression are substantially lower in some Global South countries despite high rates of suffering and adversity, reflecting both lower capacity for psychiatric diagnosis and different cultural framings of distress ^[27]. For example, depression rates in sub-Saharan Africa appear lower in epidemiological surveys than in high-income countries, but qualitative research suggests suffering may be reframed as spiritual, relational, or economic hardship rather than psychiatric illness ^[28].

Multiple evidence-based treatments exist for depression. The choice among them depends on severity, patient preference, cultural context, and access to care.

Depression is often episodic: a person experiences depressive episodes separated by periods of remission or normal mood ^[1]. However, chronic depression (lasting 2+ years) affects 20-30% of those diagnosed ^[40]. First-episode depression has roughly 50% risk of recurrence; risk increases with multiple previous episodes ^[40]. Early intervention, social support, and continued treatment reduce relapse risk. However, long-term outcomes in low-income settings are often poorer due to treatment gaps, persistent social stressors, and lack of follow-up ^[41].

Without treatment, some depression remits spontaneously; some persists or worsens. Suicide risk is present in severe depression -- approximately 10-15% of severely depressed individuals die by suicide ^[42]. However, suicide is complex and multifactorial; depression is neither necessary nor sufficient for suicide, and suicide prevention requires attention to access to means, social isolation, and other risk factors ^[42].

(1) The serotonin hypothesis is increasingly controversial: While it was widely taught as proven fact in the 2000s-2010s, recent reviews suggest the evidence is weaker than commonly claimed, and some researchers argue it has misled treatment development ^[13].

(2) Antidepressant discontinuation is poorly understood: Many patients experience withdrawal symptoms when stopping antidepressants, despite earlier claims that they were non-addictive. Protracted withdrawal syndromes lasting weeks to months are documented, yet underrecognized in clinical practice ^[43].

(3) Racial and ethnic disparities in depression diagnosis and treatment exist globally: Black, Indigenous, and other marginalized populations in high-income countries receive depression diagnoses at lower rates despite comparable or higher rates of symptoms and social stressors; when diagnosed, they receive psychotherapy less often and pharmacotherapy more often ^[44]. In low- and middle-income countries, depression in conflict-affected or colonized populations is often pathologized rather than understood as response to violence and injustice ^[45].

(4) Perinatal depression is common and often undetected: Approximately 10-15% of pregnant and postpartum people experience depression; rates are higher in low-income countries ^[46]. Yet screening and treatment are inadequate globally, with postpartum depression often attributed to normal parenting stress ^[46].

(5) Childhood depression is underdiagnosed: Depression was historically considered an adult condition, but is now recognized in children, though diagnostic criteria debate persists (whether childhood depression manifests differently than adult depression) ^[47].

(6) Depression and physical health are bidirectional: Depression increases risk of cardiovascular disease, diabetes, and chronic pain; conversely, these conditions increase depression risk. Yet medical and psychiatric care often remain siloed ^[48].

Depression is understood and treated in radically different ways across cultures, not merely because symptoms present differently, but because the frameworks for understanding human suffering differ fundamentally.

East and South Asian frameworks: Traditional Chinese medicine understands depression-like states (e.g., 郁症, yuzhen) through qi and organ system imbalances; Ayurvedic medicine links depression to vata and pitta imbalances; Japanese psychiatry has historically emphasized relational and contextual factors over individual pathology ^[49]. Contemporary Asian psychiatry integrates Western diagnostic categories with traditional frameworks -- for example, some clinicians in China and India practice both pharmacotherapy and herbal medicine ^[50].

African and diaspora perspectives: Ubuntu philosophy (humuntu ngumuntu ngabantu -- a person is a person through other persons) frames suffering as relational and communal; some African healing traditions emphasize spiritual cleansing, ancestral reconciliation, and community reintegration alongside or instead of individual treatment ^[51]. Yet African psychiatry is also heavily influenced by colonial legacies of Western diagnostic frameworks ^[52].

Indigenous and First Nations perspectives: Depression may be understood as spiritual disconnection, cultural dispossession, or the impact of historical trauma; healing may center land reconnection, cultural practice, and community solidarity ^[53]. However, Indigenous peoples also experience access barriers to both Western mental health services and traditional healing due to colonialism and resource constraints ^[53].

Critical and disability justice perspectives: Some individuals and communities reject the "disease" framing of depression entirely, understanding it as a form of neurodiversity or as legitimate political despair in response to injustice, rather than as a disorder requiring cure ^[54]. Mad studies and disability justice movements argue for supporting people with depression without necessarily pathologizing sadness itself ^[54].

Global mental health initiatives: International efforts to scale depression treatment (particularly pharmacotherapy) to low-income countries have been critiqued as Western psychiatric imperialism -- imposing biomedical frameworks on contexts where social determinants, spiritual frameworks, or community-based approaches might be more appropriate and effective ^[55]. This debate is active and unresolved.